Remix Therapeutics
Develops small molecule therapies to reprogram RNA processing.
biotechpharmaceuticals
Company facts
- Founded
- 2019
- Employees
- 56
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $60M · 2024
5 jobs
Point your AI agent at freehire and let it find you a job. A CLI and an MCP server over the whole job API — no browser.
Get the CLI →Develops small molecule therapies to reprogram RNA processing.
Company facts